Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia

Jose Perdomo Hematology Research Unit, St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia Abstract: Romiplostim is a thrombopoietin receptor agonist (TPO-RA) used for the treatment of adult primary immune thrombocytopenia (ITP). ITP is an autoimmune con...

Full description

Bibliographic Details
Main Author: Perdomo J
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:ImmunoTargets and Therapy
Subjects:
Idiopathic thrombocytopenic purpura
thrombopoietin mimetic peptide
romiplostim
splenectomy
blood platelets
Online Access:https://www.dovepress.com/role-of-romiplostim-in-splenectomized-and-nonsplenectomized-patients-w-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/role-of-romiplostim-in-splenectomized-and-nonsplenectomized-patients-w-peer-reviewed-article-ITT

Similar Items